A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
- Conditions
- Hypertension
- Interventions
- Registration Number
- NCT00627952
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Brief Summary
Eight-week multi-national, multicenter, randomized, double blind, active control, two arms, parallel groups study with a 4-week single drug treatment (manidipine or amlodipine) phase followed by a 4-week combination treatment (manidipine + delapril or amlodipine + delapril) phase.
- Detailed Description
The aim of the current study is to assess the effect of a 4-week single drug treatment with manidipine or amlodipine and a 4-week combination treatment with manidipine plus delapril or amlodipine plus delapril on intraglomerular pressure in subjects with hypertension.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- male or female patients aged 18 years or older
- mild to moderate hypertension (systolic blood pressure > 139 mmHg or diastolic blood pressure > 89 mmHg)
- secondary form of arterial hypertension
- severe hypertension (systolic blood pressure > 179 mmHg or diastolic blood pressure > 109 mmHg)
- pregnant or lactating women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description amlodipine 10 mg amlodipine 5 mg + delapril 30 mg - manidipine 20 mg manidipine 20 mg - manidipine 20 mg manidipine 10 mg + delapril 30 mg - amlodipine 10 mg amlodipine 10 mg -
- Primary Outcome Measures
Name Time Method effect of manidipine 20 mg once daily compared to amlodipine 10 mg once daily on intraglomerular pressure 4 weeks
- Secondary Outcome Measures
Name Time Method effects of combination of manidipine 10 mg plus delapril 30 mg once daily compared with once daily amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure 4 weeks
Trial Locations
- Locations (1)
Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg
🇩🇪Erlangen, Bavaria, Germany